Aequus Pharmaceuticals, Inc. (AQS.V)
0.005
0.00 (0.00%)
CAD |
TSXV |
Oct 13, 16:00
Aequus Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 52.46% |
| June 30, 2025 | 49.27% |
| March 31, 2025 | 45.65% |
| December 31, 2024 | 51.37% |
| September 30, 2024 | 28.59% |
| June 30, 2024 | 25.90% |
| March 31, 2024 | 3.61% |
| December 31, 2023 | 3.34% |
| September 30, 2023 | -237.3% |
| June 30, 2023 | 17.48% |
| March 31, 2023 | 20.04% |
| December 31, 2022 | 76.17% |
| September 30, 2022 | 83.82% |
| June 30, 2022 | 87.22% |
| March 31, 2022 | 86.27% |
| December 31, 2021 | 96.74% |
| September 30, 2021 | 93.12% |
| June 30, 2021 | 93.55% |
| Date | Value |
|---|---|
| March 31, 2021 | 92.92% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 78.92% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Body & Mind, Inc. | -- |
| Eastwood Bio-Medical Canada, Inc. | 47.66% |
| TransCanna Holdings, Inc. | -- |
| HLS Therapeutics, Inc. | 42.90% |
| Bausch Health Cos., Inc. | 65.04% |